Common Back-Pain Drug Linked to Higher Dementia Risk in Large Study

A commonly prescribed medication used to treat certain types of back pain has come under renewed attention after a large study reported an association between repeated use of the drug and a higher incidence of dementia and mild cognitive impairment.

The medication, gabapentin, is frequently used to manage nerve-related pain. It may be prescribed when back pain is accompanied by symptoms such as burning, tingling, numbness or pain that travels into the legs. While gabapentin can provide relief for some patients, researchers are now examining whether long-term exposure could have implications for cognitive health.

The findings have generated concern because dementia is becoming an increasingly important public-health issue. However, the study does not prove that gabapentin directly causes dementia. Instead, it identifies an association that researchers say deserves further investigation.

For people currently taking gabapentin, the findings should be viewed as a reason to discuss treatment with a healthcare professional rather than as a reason to suddenly stop taking the medication.

What Is Gabapentin?

Gabapentin is a prescription medication originally developed to help control seizures. It is also widely used for certain types of nerve pain.

Unlike ordinary muscle or joint pain, nerve pain can occur when nerves become irritated, compressed or damaged. This type of pain may feel sharp, burning, shooting or electric. Some people also experience numbness or pins-and-needles sensations.

Because some forms of lower-back pain involve irritated nerves, doctors may prescribe gabapentin as part of a broader treatment plan.

However, gabapentin is not necessarily effective for every form of back pain. Chronic lower-back pain can have many causes, and treatment depends on the underlying problem.

What Did the Large Study Find?

Researchers examined medical records from a large healthcare database covering many years. They focused on adults who had chronic low-back pain and compared people who had received gabapentin with similar patients who had not.

The analysis found that patients who received repeated gabapentin prescriptions had a higher incidence of dementia and mild cognitive impairment than the comparison group.

The reported association became more noticeable among people with a greater number of prescriptions. Researchers also observed particularly strong associations among some younger patients.

These findings may sound alarming, but prescription frequency alone cannot establish that the medication caused the cognitive problems.

People who require repeated prescriptions may have more severe or persistent pain, additional health problems or other characteristics that could independently influence their long-term cognitive health.

Does Gabapentin Cause Dementia?

This is the most important question—and the answer is not yet clear.

The study found an association, not proof of causation.

In medical research, an association means that two things occur together more often than expected. It does not necessarily mean that one directly caused the other.

For example, people with chronic pain may be more likely to experience poor sleep, depression, reduced physical activity and social isolation. These factors can also influence cognitive health.

Patients taking gabapentin may therefore differ from people who do not take it in ways that are difficult to completely account for in a medical-record study.

Researchers attempt to control for these differences using statistical methods, but observational studies cannot eliminate every possible source of bias.

Additional research, particularly studies designed to investigate long-term medication exposure more directly, will be needed to determine whether gabapentin itself contributes to cognitive decline.

Chronic Pain May Also Play a Role

One reason this issue is complicated is that chronic pain itself may affect the brain.

Living with persistent pain can make it difficult to sleep, concentrate or maintain normal daily activities. People experiencing ongoing discomfort may also become less physically active or socially engaged.

Over time, these changes can have broad effects on overall health and quality of life.

Some research has found relationships between chronic pain and an increased risk of cognitive problems. This means scientists need to separate the potential effects of the medication from the effects of the condition being treated.

In other words, if a person with chronic pain develops cognitive problems after taking gabapentin, it does not automatically mean that gabapentin was responsible.

Why Prescription Frequency Matters

The recent findings are particularly interesting because researchers observed differences according to the number of prescriptions patients received.

Repeated prescriptions may indicate longer or more sustained exposure to the medication. If a relationship between a drug and a health outcome becomes stronger with greater exposure, scientists may consider that an important clue.

However, this pattern still does not prove causation.

Someone receiving many prescriptions may have more severe pain than someone receiving only a few. Severe chronic pain could itself contribute to sleep problems, reduced mobility, stress and other factors associated with poorer health.

Consequently, prescription frequency needs to be interpreted alongside the patient’s overall medical history.

What Are the Possible Cognitive Effects of Gabapentin?

Gabapentin can cause side effects in some people. These may include drowsiness, dizziness, fatigue and problems with coordination.

Some patients may also report feeling mentally slowed or less alert while taking the medication.

Such effects are not the same thing as dementia.

Dementia generally involves persistent impairment in memory, thinking, communication or other cognitive abilities that interferes with everyday life. Temporary sleepiness or difficulty concentrating after taking a medication does not automatically indicate dementia.

Nevertheless, persistent or worsening cognitive symptoms should be discussed with a healthcare professional.

Who May Need to Be Particularly Careful?

Medication decisions should always be individualized.

People who are older, take multiple medications or have other medical conditions may have different risks from those of younger, healthier patients. Combining several medicines that cause drowsiness can also increase problems such as confusion, dizziness or falls.

Anyone who notices significant changes in memory, concentration, balance or alertness while taking gabapentin should mention these symptoms to their doctor or pharmacist.

A healthcare professional can review the medication list and determine whether gabapentin could be contributing to the symptoms or whether another explanation is more likely.

Should You Stop Taking Gabapentin?

People should not stop prescribed gabapentin suddenly without medical advice.

The appropriate approach is to discuss the medication with the healthcare professional who prescribed it.

Depending on the person’s circumstances, a doctor may decide that continuing treatment is appropriate. In other cases, the dose may need to be adjusted, the medication may be gradually reduced, or another treatment option may be considered.

The decision depends on why gabapentin was prescribed, how well it controls symptoms, the dose being used, how long the person has taken it and the individual’s overall health.

A single study should not determine treatment decisions for every patient.

What Can People Do About Chronic Back Pain?

Medication is only one possible part of managing chronic back pain.

Depending on the underlying cause, treatment may include physical therapy, appropriate exercise, posture and activity adjustments, weight management when appropriate, improved sleep habits and other non-drug approaches.

Some patients may also benefit from treatments aimed at the underlying source of nerve irritation or another structural problem.

The right treatment depends heavily on the cause of the pain. Back pain caused by muscle strain may require a different approach from pain associated with nerve compression, arthritis or another medical condition.

When Should Back Pain Be Evaluated?

Most episodes of back pain are not caused by a serious disease, but certain symptoms require prompt medical attention.

A person should seek medical evaluation if back pain is severe, persistent or progressively worsening, particularly when it occurs with symptoms such as significant weakness, loss of sensation, unexplained weight loss, fever or problems controlling bladder or bowel function.

New neurological symptoms should also be evaluated rather than simply treated with pain medication.

Finding the underlying cause of persistent back pain can help patients avoid relying unnecessarily on medication for long periods.

What This Means for Patients

The new findings do not mean that everyone taking gabapentin is at risk of developing dementia.

They do, however, highlight an important question about the long-term use of a medication that millions of people may encounter as part of pain management.

For patients who benefit substantially from gabapentin, the medication may still have an important role. The potential benefits of controlling severe nerve pain need to be weighed against possible side effects and individual health risks.

Regular medication reviews can help ensure that treatment remains appropriate as a person’s health changes.

The Bottom Line

A large study has raised concerns about a possible connection between repeated gabapentin use and an increased incidence of dementia and mild cognitive impairment among people with chronic low-back pain.

But an association is not the same as proof that gabapentin causes dementia.

Chronic pain itself can affect sleep, mood, activity levels and overall well-being, making it difficult to determine exactly what may contribute to cognitive decline. Differences between patients can also influence the results of observational research.

For now, people taking gabapentin should not panic or discontinue treatment on their own. Anyone concerned about memory changes, prolonged medication use or possible alternatives should have an open discussion with a healthcare professional.

The most important message is simple: gabapentin may be useful for certain patients, but long-term treatment should be regularly reviewed, and its potential cognitive effects deserve continued scientific investigation.